A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-520196-27-00

Acronym

CPIT565C12101

Enrollment

Registered

2025-07-22

Start date

2025-10-01

Completion date

Unknown

Last updated

2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, France, Germany, Hungary, Netherlands, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026